S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities

NextCure (NXTC) Earnings Date, Estimates & Call Transcripts

$1.64
-0.03 (-1.80%)
(As of 04/16/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 2Estimated
Actual EPS
(Mar. 21)
-$0.52 Beat By $0.02
Consensus EPS
(Mar. 21)
-$0.54
Skip Charts & View Estimated and Actual Earnings Data

NXTC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NXTC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NextCure Analyst EPS Estimates

Current Year EPS Consensus Estimate:($1.65) EPS
Next Year EPS Consensus Estimate: ($1.62) EPS

NXTC Earnings Date and Information

NextCure last posted its quarterly earnings data on March 21st, 2024. The reported ($0.52) earnings per share for the quarter, beating analysts' consensus estimates of ($0.54) by $0.02. NextCure has generated ($2.25) earnings per share over the last year (($2.25) diluted earnings per share). Earnings for NextCure are expected to grow in the coming year, from ($1.65) to ($1.62) per share. NextCure has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.

NextCure Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Estimated)
------- 
3/21/2024Q4 2023($0.54)($0.52)+$0.02($0.52)--
11/2/2023Q3 2023($0.64)($0.51)+$0.13($0.51)--
8/3/2023Q2 2023($0.60)($0.64)($0.04)($0.64)--
5/4/2023Q1 2023($0.64)($0.58)+$0.06($0.58)--
3/2/2023Q4 2022($0.65)($0.62)+$0.03($0.62)--
11/3/2022Q3 2022($0.60)($0.68)($0.08)($0.68)--
8/4/2022Q2 2022($0.73)($0.65)+$0.08($0.65)--
5/5/2022Q1 2022($0.68)($0.74)($0.06)($0.74)--
3/3/2022Q4 2021($0.67)($0.61)+$0.06($0.61)--
11/4/2021Q3 2021($0.67)($0.65)+$0.02($0.65)--
8/5/2021Q2 2021($0.61)($0.65)($0.04)($0.65)--
5/6/2021Q1 2021($0.59)($0.60)($0.01)($0.60)--  

NextCure Earnings - Frequently Asked Questions

When is NextCure's earnings date?

NextCure has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on NXTC's earnings history.

Did NextCure beat their earnings estimates last quarter?

In the previous quarter, NextCure (NASDAQ:NXTC) reported ($0.52) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.54) by $0.02. Learn more on analysts' earnings estimate vs. NXTC's actual earnings.

How much profit does NextCure generate each year?

NextCure (NASDAQ:NXTC) has a recorded net income of -$62.72 million. NXTC has generated -$2.25 earnings per share over the last four quarters.

What is NextCure's EPS forecast for next year?

NextCure's earnings are expected to grow from ($1.65) per share to ($1.62) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:NXTC) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners